GSK3186899
GSK3186899 is a potent and selective small molecule inhibitor of Cdc2-related kinase 12 (CRK12), demonstrating an EC50 of 1.4 μM against Leishmania donovani. This compound is a valuable chemical probe for studying kinetoplastid biology and has shown efficacy in reducing parasite load in murine models of visceral leishmaniasis.
Product Specifications
CAS Number
1972617-87-0
Product Name Alternative
CRK12, DDD853651, DDD-853651, DDD 853651, 3,3,3-trifluoro-N-[4-[[3-[ (2R) -2-methylmorpholin-4-yl]-1H-pyrazolo[3,4-d]pyrimidin-6-yl]amino]cyclohexyl]propane-1-sulfonamide, L. donovani, GSK 3186899, GSK3186899, GSK-3186899
Field of Research
Infectious Disease & Virology
Purity
98.00% (May vary between batches)
Solubility
DMSO:200 mg/mL (406.89 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (10.17 mM)
Smiles
C[C@H]1CN (CCO1) c1n[nH]c2nc (N[C@H]3CC[C@@H] (CC3) NS (=O) (=O) CCC (F) (F) F) ncc12
Molecular Formula
C19H28F3N7O3S
Molecular Weight
491.53
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1309003 1.0 µg DNA
MLN sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details 